Search

Elli Peselev

Examiner (ID: 6644)

Most Active Art Unit
1623
Art Unit(s)
1803, 1673, 1211, 2899, 1623, 1621, 1203, 1802
Total Applications
2819
Issued Applications
1827
Pending Applications
143
Abandoned Applications
853

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10142232 [patent_doc_number] => 09175031 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Ketolide compounds' [patent_app_type] => utility [patent_app_number] => 13/991762 [patent_app_country] => US [patent_app_date] => 2011-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24481 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991762 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/991762
Ketolide compounds Feb 2, 2011 Issued
Array ( [id] => 6212414 [patent_doc_number] => 20110135714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYL COBALAMIN FOR IMPROVEMENT OF SKIN DISEASES' [patent_app_type] => utility [patent_app_number] => 13/016682 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7316 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135714.pdf [firstpage_image] =>[orig_patent_app_number] => 13016682 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/016682
COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYL COBALAMIN FOR IMPROVEMENT OF SKIN DISEASES Jan 27, 2011 Abandoned
Array ( [id] => 9977701 [patent_doc_number] => 09024012 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form' [patent_app_type] => utility [patent_app_number] => 13/575751 [patent_app_country] => US [patent_app_date] => 2011-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12057 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575751 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/575751
Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form Jan 26, 2011 Issued
Array ( [id] => 10870412 [patent_doc_number] => 08895610 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-11-25 [patent_title] => 'Platinum (IV) compounds targeting zinc finger domains' [patent_app_type] => utility [patent_app_number] => 13/011613 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 27946 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13011613 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/011613
Platinum (IV) compounds targeting zinc finger domains Jan 20, 2011 Issued
Array ( [id] => 8854163 [patent_doc_number] => 20130143837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'INHIBITION OF TNF-ALPHA INDUCED ACTIVATION OF NFKB BY PENTOSAN POLYSULFATE' [patent_app_type] => utility [patent_app_number] => 13/522441 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 24117 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13522441 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/522441
Inhibition of TNF-α induced activation of NFKB by pentosan polysulfate Jan 13, 2011 Issued
Array ( [id] => 9299822 [patent_doc_number] => 08648050 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-11 [patent_title] => 'Methods and formulations for reducing amphotericin B treatment side effects' [patent_app_type] => utility [patent_app_number] => 12/985256 [patent_app_country] => US [patent_app_date] => 2011-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19580 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12985256 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/985256
Methods and formulations for reducing amphotericin B treatment side effects Jan 4, 2011 Issued
Array ( [id] => 5984821 [patent_doc_number] => 20110097412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'METHODS OF TREATMENT OF ENDOBRONCHIAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/984110 [patent_app_country] => US [patent_app_date] => 2011-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21274 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097412.pdf [firstpage_image] =>[orig_patent_app_number] => 12984110 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/984110
METHODS OF TREATMENT OF ENDOBRONCHIAL INFECTIONS Jan 3, 2011 Abandoned
Array ( [id] => 8780579 [patent_doc_number] => 20130102554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'COMPOSITION FOR TREATMENT OF OBESITY USING WHEAT BRAN EXTRACT OR ACTIVE INGREDIENT ISOLATED THEREFROM' [patent_app_type] => utility [patent_app_number] => 13/520161 [patent_app_country] => US [patent_app_date] => 2010-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 6014 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520161 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/520161
COMPOSITION FOR TREATMENT OF OBESITY USING WHEAT BRAN EXTRACT OR ACTIVE INGREDIENT ISOLATED THEREFROM Dec 29, 2010 Abandoned
Array ( [id] => 8618178 [patent_doc_number] => 20130023489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING DISEASES AND ENVIRONMENTALLY INDUCED HEALTH DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/519049 [patent_app_country] => US [patent_app_date] => 2010-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 27337 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519049 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/519049
COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING DISEASES AND ENVIRONMENTALLY INDUCED HEALTH DISORDERS Dec 23, 2010 Abandoned
Array ( [id] => 7791775 [patent_doc_number] => 20120053331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'GLYCOL CHITOSAN DERIVATIVE, PREPARATION METHOD THEREOF AND DRUG DELIVERY SYSTEM COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/974841 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4063 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053331.pdf [firstpage_image] =>[orig_patent_app_number] => 12974841 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/974841
Glycol chitosan derivative, preparation method thereof and drug delivery system comprising the same Dec 20, 2010 Issued
Array ( [id] => 10533774 [patent_doc_number] => 09259389 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Pharmaceutical oral dosage form containing a synthetic oligosaccharide' [patent_app_type] => utility [patent_app_number] => 13/515965 [patent_app_country] => US [patent_app_date] => 2010-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15213 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515965 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/515965
Pharmaceutical oral dosage form containing a synthetic oligosaccharide Dec 16, 2010 Issued
Array ( [id] => 8697796 [patent_doc_number] => 20130059805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'COMPOSITION COMPRISING AN AMORPHOUS NON-CRYSTALLINE GLASS FORM OF AZITHROMYCIN' [patent_app_type] => utility [patent_app_number] => 13/516942 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4161 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516942 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/516942
COMPOSITION COMPRISING AN AMORPHOUS NON-CRYSTALLINE GLASS FORM OF AZITHROMYCIN Dec 14, 2010 Abandoned
Array ( [id] => 8671397 [patent_doc_number] => 20130045936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-21 [patent_title] => 'COMPOSITION COMPRISING AN AMORPHOUS NON-CRYSTALLINE GLASS FORM OF ROXITHROMYCIN' [patent_app_type] => utility [patent_app_number] => 13/516864 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2987 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516864 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/516864
Composition comprising an amorphous non-crystalline glass form of roxithromycin Dec 14, 2010 Issued
Array ( [id] => 6213913 [patent_doc_number] => 20110136752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'NOVEL ANTIBIOTICS' [patent_app_type] => utility [patent_app_number] => 12/960973 [patent_app_country] => US [patent_app_date] => 2010-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13508 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136752.pdf [firstpage_image] =>[orig_patent_app_number] => 12960973 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/960973
NOVEL ANTIBIOTICS Dec 5, 2010 Abandoned
Array ( [id] => 6125510 [patent_doc_number] => 20110086053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'Glycolipids And Analogues Thereof As Antigens For NKT Cells' [patent_app_type] => utility [patent_app_number] => 12/958996 [patent_app_country] => US [patent_app_date] => 2010-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 29922 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086053.pdf [firstpage_image] =>[orig_patent_app_number] => 12958996 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/958996
Glycolipids and analogues thereof as antigens for NKT cells Dec 1, 2010 Issued
Array ( [id] => 5986774 [patent_doc_number] => 20110098260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Steroid Compounds and Formulations' [patent_app_type] => utility [patent_app_number] => 12/957661 [patent_app_country] => US [patent_app_date] => 2010-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 64620 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098260.pdf [firstpage_image] =>[orig_patent_app_number] => 12957661 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/957661
Steroid compounds and formulations Nov 30, 2010 Issued
Array ( [id] => 6039473 [patent_doc_number] => 20110092522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Wound and Skin Care Procuts' [patent_app_type] => utility [patent_app_number] => 12/952633 [patent_app_country] => US [patent_app_date] => 2010-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17088 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092522.pdf [firstpage_image] =>[orig_patent_app_number] => 12952633 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/952633
Wound and skin care compositions Nov 22, 2010 Issued
Array ( [id] => 8829956 [patent_doc_number] => 20130131001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'Epirubicin Derivatives' [patent_app_type] => utility [patent_app_number] => 13/508035 [patent_app_country] => US [patent_app_date] => 2010-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11811 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508035 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/508035
Epirubicin derivatives Nov 2, 2010 Issued
Array ( [id] => 8187177 [patent_doc_number] => 20120116066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM' [patent_app_type] => utility [patent_app_number] => 12/915864 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17969 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20120116066.pdf [firstpage_image] =>[orig_patent_app_number] => 12915864 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/915864
Efficient and scalable process for the manufacture of Fondaparinux sodium Oct 28, 2010 Issued
Array ( [id] => 8359593 [patent_doc_number] => 20120214753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION' [patent_app_type] => utility [patent_app_number] => 13/502453 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7587 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502453 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/502453
PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION Oct 21, 2010 Abandoned
Menu